Breast Cancer

Pfizer: Experimental Breast Cancer Treatment Shows Promise

The pharma firm reports that the treatment has show effectiveness in slowing the progression of advanced breast cancer.

Pfizer Inc. said Wednesday that an experimental breast cancer drug it is developing was more effective than an older therapy at slowing the progression of advanced breast cancer.

Your rating: None Average: 5 (1 vote)

Novartis Lands FDA Approval for Afinitor in Advanced Breast Cancer

The tablets have been approved for treatment of postmenopausal women in combination with exemestane.

The US Food and Drug Administration (FDA) has approved Afinitor (everolimus) tablets for the treatment of postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer (advanced HR+ breast cancer) in combination with exemestane after failure of treatment with letrozole or anastrozole.

No votes yet
Syndicate content